Market Pulse: Yesterday’s rally was driven by a crypto surge after Bitcoin topped $80,000, igniting a fresh short squeeze that sent Coinbase shares sharply higher.
Key Movers: Crypto equities led the charge—see “Strategy Climbs 12%, Coinbase Jumps 10% as Bitcoin Tops $80,000” (24/7 Wall St.) and Decrypt’s “Bitcoin Blasts Past $80K and a Fresh Short Squeeze Is On,” while BioMarin-Amicus merger chatter and RARE’s FDA watch fueled biotech sentiment.
Macro & Politics: The CLARITY Act Stalls in Senate as Crypto-Related Stocks Decline (Naturalnews.com) underscores growing regulatory drag, and Montana Is Trying To Break the FDA’s Monopoly on Experimental Treatments (Reason) adds a state-versus-feds twist.
What’s Next: Watch for the pending Fayuvi FDA decision and any Fed remarks later today.
Unfiltered Market Commentary
Everyone’s overlooking the real elephant in the room: regulatory hangover. “CLARITY Act Stalls in Senate as Crypto-Related Stocks Decline” (Naturalnews.com) barely scratches the surface—every extension of uncertainty is a damn volatility minefield for digital assets.
The way Bitcoin’s short liquidations triggered a cascade in 24/7 Wall St.’s “Strategy Climbs 12%, Coinbase Jumps 10% as Bitcoin Tops $80,000” and BioMarin Targets Amicus Synergies as VOXZOGO Nears $1B Milestone (MarketBeat) shows that when hype meets a tangible catalyst, markets go berserk—and you’ll miss it if you don’t ride both waves.
Don’t get suckered by the next headline—tighten your stops, pick your catalysts, and focus on Decrypt’s “Bitcoin Blasts Past $80K and a Fresh Short Squeeze Is On” alongside EconomicTimes.com’s “Can Fayuvi FDA approval lift RARE stock further?” to stay ahead.
📈 Breaking Financial News
Strategy Climbs 12%, Coinbase Jumps 10% as Bitcoin Tops $80,000
Bitcoin crossing a key threshold triggered a cascade of short liquidations that sent crypto equities flying well past the coin itself, and the regulatory mov…
Apple Stock Has a New Opportunity Investors Can’t Afford to Ignore
Apple just posted its ninth consecutive earnings beat and shares are up 23% this year, yet the stock may still be dramatically underpriced for what comes nex…
Bitcoin Blasts Past $80K and a Fresh Short Squeeze Is On
Bitcoin just ripped 5.88% higher in a single session, tearing back toward its 2026 highs. The charts say the move is real, but they also say it's gotten ahead of itself.
Can Fayuvi FDA approval lift RARE stock further?
Ultragenyx Pharmaceutical shares jumped 12.6% to $14.50 on September 17 after the FDA approved Fayuvi, a gene therapy for children with Sanfilippo syndrome Type A. RARE stock jumps 13%
Avis Budget Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Avis Budget Group, Inc. – CAR
NEW ORLEANS, Sept. 18, 2026 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 29, 2026 to file lead plaintiff applications in a securities class action lawsuit against Avis Budget Group, Inc.…
Jensen Huang Is Quietly Building What He Calls the Largest Technology Industry the World Has Ever Seen
Wall Street is still counting GPU shipments. Morgan Stanley says this new Nvidia-backed market touches $60 trillion, and Goldman Sachs expects it to explode in 2026. One analyst has named three small companies at its center.
🔍 Market Analysis & Insights
Capricor Therapeutics, Inc. Stockholders with Significant Losses Should Contact Robbins LLP Before the Pending September 28, 2026 Lead Plaintiff Deadline
SAN DIEGO, Sept. 18, 2026 /PRNewswire/ — Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between Dece…
Teva Announces New Olanzapine LAI (TEV-’749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults
In a post hoc analysis of the open-label safety stage of the Phase 3 SOLARIS trial, more than half of participants receiving TEV-’749 achieved stabilization, few relapsed and more than one-fifth of participants receiving TEV-’749 for ≥ 6 months met criteria f…
Remote Patient Monitoring Market to Reach US$ 62.2 Bn by 2031, Growing at 12.5% CAGR, Driven by Hospital-at-Home Expansion: Wissen Research
SHERIDAN, Wyo., Sept. 18, 2026 /PRNewswire/ — The global remote patient monitoring market is projected to grow from USD 34.5 billion in 2026 to USD 62.2 billion by 2031, registering a CAGR of 12.5% during the forecast period (2026–2031), according to a new s…
Nscale files for IPO, seeks to list on NYSE under symbol ‘NSCL'
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Bitcoin rises 6% as lower oil prices and SEC decision boost market
Bitcoin's rise highlights the impact of regulatory shifts and market dynamics on digital assets, signaling potential volatility ahead.
The post Bitcoin rises 6% as lower oil prices and SEC decision boost market appeared first on Crypto Briefing.
The Hidden Government Project JPMorgan Is Pouring Over a Trillion Dollars Into
As the tech race with China nears a breaking point, Washington has restarted a decade-old effort called Project Phoenix. Two tiny companies trading under $10 are the only ones that can deliver on its mission — and big banks are quietly buying in.
💰 Investment Opportunities
BioMarin Targets Amicus Synergies as VOXZOGO Nears $1B Milestone
BioMarin Pharmaceutical (NASDAQ:BMRN) said it is progressing with the integration of Amicus Therapeutics while pursuing additional business-development oppor…
Why Bitcoin hit $80k today hours before bad US data even landed
The September 18 advance accompanied a tech rebound and yen weakness, while prior-session ETF inflows offered a tentative demand signal.
The post Why Bitcoin hit $80k today hours before bad US data even landed appeared first on CryptoSlate.
Montana Is Trying To Break the FDA's Monopoly on Experimental Treatments
Montana’s expanded right-to-try program has cleared its first therapy: a sound-and-antihistamine regimen intended to reverse hearing loss.
AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR® (cariprazine) at Psych Congress 2026
New data from prospective real-world studies of VRAYLAR showed meaningful improvements in depressive symptoms, functioning and quality of life among adults living with major depressive disorder (MDD) and bipolar I (BP-I) depression These findings provide addi…
CLARITY Act Stalls in Senate as Crypto-Related Stocks Decline
Shares of major cryptocurrency-related companies fell sharply after the U.S. Senate failed to advance the CLARITY Act, a bill that would have established a regulatory framework for digital assets. The procedural vote, which took place during the current congr…
This $5 Stock's Patented Tech Powers SpaceX's Most Profitable Division
Satellite constellations are worthless unless the data gets to the ground fast. Ross Givens says one tiny firm solved that physics problem — and is the only company that can supply the component at commercial scale. His new report is free for now.